Yu H - Search Results

1

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.

Chen X, Cao Z, Liu Y, Zhang H, Zhang Y, Ma L, Jin Y, Yu H, Ma B, Zheng Y, Wu H. Chen X, et al. Among authors: yu h. J Gastroenterol Hepatol. 2012 Mar;27(3):481-6. doi: 10.1111/j.1440-1746.2011.06970.x. J Gastroenterol Hepatol. 2012. PMID: 22098411

2

Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection.

Ren S, Yu H, Zhang H, Liu Y, Huang Y, Ma L, Wei L, Wu H, Chen X. Ren S, et al. Among authors: yu h. Antiviral Res. 2011 Mar;89(3):232-7. doi: 10.1016/j.antiviral.2011.01.006. Epub 2011 Jan 28. Antiviral Res. 2011. PMID: 21277331

3

[The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].

Zhang XD, Ren S, Yu HB, Liu YL, Jin Y, Huang YX, Chen JM, Chen XY. Zhang XD, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Sep;19(9):674-7. doi: 10.3760/cma.j.issn.1007-3418.2011.09.010. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152382 Chinese.

4

Clinical features and risk factors of acute hepatitis E with severe jaundice.

Xu B, Yu HB, Hui W, He JL, Wei LL, Wang Z, Guo XH. Xu B, et al. World J Gastroenterol. 2012 Dec 28;18(48):7279-84. doi: 10.3748/wjg.v18.i48.7279. World J Gastroenterol. 2012. PMID: 23326133 Free PMC article.

5

[Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].

Yu HB, Ma LN, Liu YL, Hua W, He ZM, Lu JF, Chen XY. Yu HB, et al. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):895-8. doi: 10.3760/cma.j.issn.1007-3418.2013.12.004. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24636289 Chinese.

6

Liver stiffness measurement is a potent predictor of histological fibrosis regression after hepatitis C virus clearance.

Qiu LX, Liu YL, Lin W, Liu YR, Yu HB, Wang XX, Sun YM, Jin RH, Hu ZJ, Zhang J. Qiu LX, et al. Eur J Gastroenterol Hepatol. 2021 Apr 1;33(4):547-554. doi: 10.1097/MEG.0000000000001749. Eur J Gastroenterol Hepatol. 2021. PMID: 32453007 Free PMC article.

7

Low Mannose Binding Lectin, but Not L-Ficolin, Is Associated With Spontaneous Clearance of Hepatitis C Virus After Infection.

Zhang J, Chen N, Chen Z, Liu Y, Zheng K, Qiu Y, Zhang N, Zhu J, Yu H, He Q. Zhang J, et al. Among authors: yu h. Front Immunol. 2020 Nov 11;11:587669. doi: 10.3389/fimmu.2020.587669. eCollection 2020. Front Immunol. 2020. PMID: 33262767 Free PMC article.

8

Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids.

Du X, Liu Z, Yu H, Wang Y, Zou Z, Wei H, Liang J, Yang D, Liu Y, Zhang J, Pan CQ. Du X, et al. Among authors: yu h. Medicine (Baltimore). 2023 Aug 11;102(32):e34698. doi: 10.1097/MD.0000000000034698. Medicine (Baltimore). 2023. PMID: 37565875 Free PMC article.

9

Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.

Mei T, Huang X, Tang S, Liu M, Zhang W, Yu H. Mei T, et al. Among authors: yu h. Lipids Health Dis. 2024 Mar 9;23(1):74. doi: 10.1186/s12944-023-01957-2. Lipids Health Dis. 2024. PMID: 38461262 Free PMC article.

10

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.

Tang S, Zhang J, Mei TT, Guo HQ, Wei XH, Zhang WY, Liu YL, Liang S, Fan ZP, Ma LX, Lin W, Liu YR, Qiu LX, Yu HB. Tang S, et al. BMC Cancer. 2019 Nov 21;19(1):1128. doi: 10.1186/s12885-019-6173-4. BMC Cancer. 2019. PMID: 31752753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,326 results

Search Page

Filters